Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 18 studies | 28% ± 13% | |
endothelial cell | 17 studies | 29% ± 7% | |
fibroblast | 15 studies | 27% ± 8% | |
T cell | 14 studies | 28% ± 10% | |
natural killer cell | 14 studies | 28% ± 13% | |
pericyte | 11 studies | 29% ± 7% | |
CD8-positive, alpha-beta T cell | 11 studies | 28% ± 14% | |
smooth muscle cell | 10 studies | 24% ± 7% | |
plasmacytoid dendritic cell | 10 studies | 26% ± 11% | |
CD4-positive, alpha-beta T cell | 9 studies | 30% ± 16% | |
naive B cell | 7 studies | 27% ± 10% | |
regulatory T cell | 7 studies | 22% ± 6% | |
macrophage | 6 studies | 22% ± 5% | |
capillary endothelial cell | 6 studies | 30% ± 10% | |
abnormal cell | 6 studies | 29% ± 8% | |
conventional dendritic cell | 6 studies | 20% ± 5% | |
gamma-delta T cell | 6 studies | 32% ± 14% | |
plasma cell | 6 studies | 31% ± 14% | |
epithelial cell | 6 studies | 33% ± 18% | |
astrocyte | 6 studies | 32% ± 10% | |
endothelial cell of lymphatic vessel | 5 studies | 24% ± 5% | |
mature NK T cell | 5 studies | 26% ± 8% | |
myofibroblast cell | 5 studies | 22% ± 5% | |
vein endothelial cell | 5 studies | 23% ± 8% | |
retinal rod cell | 5 studies | 29% ± 10% | |
oligodendrocyte precursor cell | 5 studies | 26% ± 9% | |
mast cell | 4 studies | 27% ± 11% | |
type I pneumocyte | 4 studies | 28% ± 8% | |
progenitor cell | 4 studies | 20% ± 2% | |
connective tissue cell | 4 studies | 25% ± 8% | |
goblet cell | 4 studies | 20% ± 5% | |
memory B cell | 4 studies | 28% ± 9% | |
amacrine cell | 4 studies | 43% ± 13% | |
retinal cone cell | 4 studies | 42% ± 21% | |
myeloid cell | 4 studies | 37% ± 6% | |
ciliated cell | 4 studies | 29% ± 8% | |
GABAergic neuron | 4 studies | 35% ± 20% | |
glutamatergic neuron | 4 studies | 40% ± 26% | |
microglial cell | 4 studies | 29% ± 5% | |
interneuron | 4 studies | 28% ± 11% | |
dendritic cell | 3 studies | 46% ± 26% | |
monocyte | 3 studies | 29% ± 8% | |
type II pneumocyte | 3 studies | 23% ± 10% | |
classical monocyte | 3 studies | 30% ± 13% | |
leukocyte | 3 studies | 18% ± 2% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
endothelial cell of artery | 3 studies | 28% ± 17% | |
T follicular helper cell | 3 studies | 42% ± 13% | |
transit amplifying cell | 3 studies | 17% ± 1% | |
retinal bipolar neuron | 3 studies | 42% ± 9% | |
mucosal invariant T cell | 3 studies | 19% ± 3% | |
lymphocyte | 3 studies | 32% ± 7% | |
oligodendrocyte | 3 studies | 24% ± 7% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 27% ± 3% | |
brush cell | 3 studies | 20% ± 4% | |
basal cell | 3 studies | 29% ± 18% | |
enteroendocrine cell | 3 studies | 29% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 672.11 | 1444 / 1445 | 94% | 3.42 | 172 / 183 |
ovary | 100% | 560.93 | 180 / 180 | 82% | 2.42 | 352 / 430 |
thymus | 100% | 723.98 | 653 / 653 | 80% | 2.79 | 484 / 605 |
uterus | 100% | 605.94 | 170 / 170 | 75% | 3.29 | 345 / 459 |
brain | 99% | 360.88 | 2612 / 2642 | 66% | 1.50 | 464 / 705 |
lung | 100% | 515.51 | 577 / 578 | 64% | 1.91 | 739 / 1155 |
bladder | 100% | 590.95 | 21 / 21 | 62% | 2.41 | 313 / 504 |
breast | 100% | 499.08 | 459 / 459 | 55% | 1.33 | 611 / 1118 |
pancreas | 98% | 319.12 | 322 / 328 | 54% | 1.19 | 97 / 178 |
stomach | 100% | 384.73 | 358 / 359 | 52% | 1.11 | 148 / 286 |
kidney | 100% | 519.58 | 89 / 89 | 45% | 1.02 | 408 / 901 |
prostate | 100% | 650.30 | 245 / 245 | 43% | 0.84 | 217 / 502 |
intestine | 100% | 514.15 | 966 / 966 | 40% | 0.82 | 211 / 527 |
skin | 100% | 471.39 | 1806 / 1809 | 33% | 0.54 | 156 / 472 |
adrenal gland | 100% | 372.16 | 258 / 258 | 24% | 0.36 | 55 / 230 |
liver | 99% | 270.77 | 223 / 226 | 23% | 0.44 | 95 / 406 |
adipose | 100% | 450.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 825.17 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 43.42 | 1 / 1 |
blood vessel | 100% | 399.00 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 448.63 | 910 / 929 | 0% | 0 | 0 / 0 |
muscle | 97% | 261.18 | 777 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 274.89 | 832 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 5.47 | 34 / 45 |
lymph node | 0% | 0 | 0 / 0 | 52% | 0.95 | 15 / 29 |
eye | 0% | 0 | 0 / 0 | 9% | 0.11 | 7 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0005665 | Cellular component | RNA polymerase II, core complex |
GO_0003677 | Molecular function | DNA binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0001055 | Molecular function | RNA polymerase II activity |
Gene name | POLR2J3 |
Protein name | RNA polymerase II subunit J3 DNA-directed RNA polymerase II subunit RPB11-b2 (RNA polymerase II subunit B11-b2) (RPB11b2) (DNA-directed RNA polymerase II subunit J3) |
Synonyms | |
Description | FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB11 is part of the core element with the central large cleft (By similarity). . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB11 is part of the core element with the central large cleft. . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB11 is part of the core element with the central large cleft. . |
Accessions | D6RAG0 A0A0B4J1Z8 E7EWC6 ENST00000513506.6 ENST00000507355.5 ENST00000379340.9 ENST00000508848.5 ENST00000621093.5 ENST00000486319.5 E7EP90 ENST00000489144.5 ENST00000464525.5 E2QRJ6 ENST00000513438.1 F8WF84 Q9H1A7 A0A0B4J2F8 ENST00000511313.5 ENST00000608621.5 |